Senate confirms Trump picks amid party-line divisions

27 March 2025

The US Senate has confirmed President Donald Trump’s nominees to lead two of the country’s top health agencies, approving surgeon Marty Makary as Commissioner of the Food and Drug Administration and economist and physician Jay Bhattacharya as director of the National Institutes of Health.

Dr Makary, a public health researcher and professor at Johns Hopkins University, secured confirmation in a 56-44 vote, with support from three Democrats. Dr Bhattacharya, a professor at Stanford University, was confirmed by a narrower 53-47 vote, backed only by Republicans.

Both officials were nominated amid growing debate over the direction of federal health policy under Trump’s second term. During their confirmation hearings earlier this month, the pair faced pointed questions over their views on vaccines and pandemic-era mandates, especially in light of their past criticism of masking and school closures during COVID-19.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical